WESTPORT, CT and MEXICO CITY – INVISTA has authorized Megafarma, an Azelis company, to distribute its DYTEK® Specialty Amine portfolio in Mexico. This includes DYTEK® Amine, DYTEK®DCH-99, DYTEK®HMI, and DYTEK®BHMT products. With this new mandate, Megafarma’s CASE Division, will service customers across Mexico, with the INVISTA DYTEK® Specialty Amine portfolio. The agreement is effective June 1, 2020.
Highlights & rationale
- This new mandate continues to build on Azelis’ strategic acquisition of Megafarma to expand into the Latin American CASE market.
- It aligns with Azelis’ corporate strategy of organic growth and solidifies the growth of Azelis Americas and Megafarma through the expansion of relationships of Key Principals into Mexico.
- The mandate leverages existing Azelis Americas CASE assets, including application labs, digital platforms, technical and market intelligence, in the Mexican market.
Martin Hernandez Gutiérrez, Director General at Megafarma, an Azelis company, comments:
“Now that we are part of the Azelis family, this agreement is an example of our commitment to expand into the CASE sector and become a leading distributor with unsurpassed quality, logistics and technical support for our customers and principals.”
Dan Gruber, Managing Director, Principal Development, Azelis Americas CASE, says:
“We have a longstanding relationship with INVISTA in the U.S. The expansion of our relationship into the Mexican market allows us to deliver the same value and growth that we have provided INVISTA in the U.S.”
“INVISTA is excited to move forward with Megafarma representing our DYTEK® Specialty Amines,” says Kris Mitchell, DYTEK® Specialties Global Business Director. “Megafarma will support our existing and new customers in Mexico via local inventory, technical assistance, and local sales representatives in every region of Mexico.”
Lucia Zamudio, CASE Sales Director, Megafarma, an Azelis company, adds:
“We have built a team of excellent, experienced technical sales representatives for the CASE market that is now ready to aggressively pursue new business for INVISTA. We have confidence that we will bring the same high quality of ingredients and service to Mexico that we have been known for in the U.S.”
INVISTA DYTEK® Specialty Intermediates provide the amines used in curing agents for composites and laminates. The DYTEK portfolio consists of multifunctional amines developed to enable R&D chemists, formulators and manufacturers to introduce new and differentiated products, discover new routes in organic synthesis, and advance new chemistry.
From the fibers in your carpet to the plastic in your automobiles, INVISTA’s commitment to continuous improvement has led its employees to develop some of the most durable, versatile polymers and fibers in the world. A subsidiary of Koch Industries since 2004, INVISTA brings to market the proprietary ingredients for nylon 6,6 and recognized brands including STAINMASTER®, CORDURA® and ANTRON®. INVISTA also offers specialty chemical intermediates and process technologies. See the bigger picture at www.INVISTA.com.
Azelis is a leading distributor of specialty chemicals and food ingredients present in over 50 countries across the globe with around 2,200 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to about 40,000 customers, creating a turnover of $2.37 billion (2019). In the US we operate under a number of renowned co-brands that cater to the various markets in the region.
Throughout our extensive network of more than 60 application laboratories, our award-winning technical staff help customers develop formulations. We combine a global reach with a local focus to offer a reliable, integrated service to local customers and attractive business opportunities to principals. And we believe in building and nurturing solid, honest and transparent relationships with our people and partners.
Impact through ideas. Innovation through formulation.
Megafarma, an Azelis company, CASE Division
T: +(55) 5293 8797 (office)
E: [email protected]
T: 203 883 1477
E: [email protected]